Comprehensive Analysis of National Action Plans for AMR Containment in SEAR
In Southeast Asia Region (SEAR), a high-risk area for antimicrobial resistance (AMR), qualitative risk analysis indicates a significant AMR threat. The region has implemented comprehensive policies and developed National Action Plans (NAPs) to combat AMR. A specialized situation analysis tool, focus
0 views • 6 slides
Pharmaceutical Innovations in India's Drug Development Landscape
India has been a key player in drug development efforts, with organizations like CDRI, DRDO, and Ranbaxy leading the way in producing a diverse range of therapeutic molecules. With 87% of WHO-prequalified drugs in the SEAR region manufactured in India, the country has made significant contributions
0 views • 62 slides